CORE Biomedicine, Inc. がん領域をはじめとする医薬品の研究・開発
2 known investors
CORE Biomedicine develops precision oncology therapeutics targeting core lineage-dependent pathways in cancer, moving beyond genomic approaches to address fundamental biological programs driving tumor survival and therapy resistance.
BiotechDigital HealthMedical Devices